Investor profile
NCL Technology Ventures Ltd
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
NCL Investment Management is a specialist healthcare investor that invests transformational equity capital in entrepreneurs with truly innovative technologies. The firm believes that "the modernisation of healthcare will be one of the greatest growth drivers of the 21st century" and focuses on pioneers actively using innovation and technological advancement to help prevent, treat, and cure a wide range of conditions. NCL creates value by identifying companies at the forefront of transformational change and applying both capital and human skills to navigate the rapidly evolving healthcare sector, preparing portfolio companies to succeed both clinically and commercially. The firm targets pre-seed, seed, seed-plus, and Series A stage companies across healthcare technology, medtech, biotech, digital health, and therapeutics, providing hands-on support through clinical trials, regulatory approvals, reimbursement strategies, and market access.
Notable quotes
“Communicate has always been excellent at telling us what systems we would need, how we could evolve our own business and how we can make efficiencies within our underlying businesses as well.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Ampersand Health | Seed | — | — |
| Azadyne | Seed | — | — |
| Centauri Therapeutics | Seed | — | — |
| Curesponse | Series A | — | 2020-06-05 |
| Emteq Labs | Seed | — | — |
| Revolo Biotherapeutics | Seed | — | — |
| Sana Health | Seed | — | — |
| TC Biopharm | Seed | — | — |
| Viramel | Seed | — | — |
| Andiamo | Seed | $2m | 2018-03-16 |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| 24 Haymarket | 2 |
| SOSV | 2 |
| aMoon Fund | 1 |
| SyndicateRoom | 1 |
| WeWork Creator Fund | 1 |
| SBRI Healthcare | 1 |
Fit check
Is NCL Technology Ventures Ltd a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit